Stockscreener 앱 받기
44.06
0.02%
-0.010
시간 외 거래:
44.06
전일 마감가:
$44.07
열려 있는:
$44.07
하루 거래량:
1.06M
Relative Volume:
1.32
시가총액:
$2.01B
수익:
$1.24B
순이익/손실:
$23.68M
주가수익비율:
104.90
EPS:
0.42
순현금흐름:
$108.67M
1주 성능:
+19.79%
1개월 성능:
+23.35%
6개월 성능:
-14.66%
1년 성능:
-28.88%
1일 변동 폭
$43.88
$44.98
1주일 범위
$35.00
$44.98
52주 변동 폭
$32.48
$63.57
Livanova Plc Stock (LIVN) Company Profile
명칭
Livanova Plc
전화
4402033250662
주소
20 EASTBOURNE TERRACE, LONDON
LIVN을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
LIVN
Livanova Plc
|
44.06 | 2.01B | 1.24B | 23.68M | 108.67M | 0.42 |
|
ABT
Abbott Laboratories
|
133.24 | 231.09B | 42.34B | 13.50B | 6.66B | 7.71 |
|
BSX
Boston Scientific Corp
|
102.86 | 155.24B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
380.92 | 144.54B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
83.48 | 108.82B | 33.20B | 4.26B | 5.47B | 3.29 |
|
EW
Edwards Lifesciences Corp
|
73.68 | 44.31B | 5.54B | 4.18B | 623.10M | 7.00 |
Livanova Plc Stock (LIVN) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-02-26 | 다운그레이드 | Wolfe Research | Outperform → Peer Perform |
| 2024-10-04 | 개시 | Goldman | Buy |
| 2024-09-17 | 업그레이드 | Robert W. Baird | Neutral → Outperform |
| 2024-03-20 | 재확인 | Needham | Buy |
| 2024-02-20 | 업그레이드 | Mizuho | Neutral → Buy |
| 2023-09-06 | 개시 | HSBC Securities | Hold |
| 2023-07-19 | 개시 | Robert W. Baird | Neutral |
| 2023-04-14 | 개시 | Mizuho | Neutral |
| 2022-12-21 | 개시 | Barclays | Equal Weight |
| 2022-04-06 | 개시 | Wolfe Research | Outperform |
| 2022-02-24 | 업그레이드 | UBS | Neutral → Buy |
| 2021-12-03 | 개시 | Goldman | Buy |
| 2021-08-20 | 재확인 | Needham | Buy |
| 2021-07-20 | 업그레이드 | Needham | Hold → Buy |
| 2021-03-03 | 다운그레이드 | Berenberg | Buy → Hold |
| 2021-01-05 | 다운그레이드 | Needham | Buy → Hold |
| 2020-09-02 | 개시 | Robert W. Baird | Outperform |
| 2020-06-26 | 재확인 | Needham | Buy |
| 2019-10-30 | 재확인 | Needham | Buy |
| 2019-02-28 | 재확인 | Needham | Buy |
| 2018-11-28 | 개시 | UBS | Neutral |
| 2018-08-02 | 재확인 | Needham | Buy |
| 2018-06-08 | 개시 | Stifel | Buy |
| 2018-05-31 | 재확인 | Needham | Buy |
| 2018-02-28 | 재확인 | Needham | Buy |
모두보기
Livanova Plc 주식(LIVN)의 최신 뉴스
Vagus Nerve Stimulators Market Is Booming Worldwide | LivaNova - openPR.com
New Trial Reveals Sustained Benefits for Investigational Sleep Apnea Neurostimulator - Sleep Review
Jefferies lifts Livanova stock price target to $79 from $74 - Investing.com Australia
LivaNova (LIVN) Receives Price Target Boost from Baird | LIVN Stock News - GuruFocus
LivaNova Q1 2025 revenue increases 7.4% to USD 316.9M - Medical Buyer
Barclays Adjusts LivaNova (LIVN) Price Target Amid Strong Performance | LIVN Stock News - GuruFocus
LivaNova PLC (LIVN) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic Advances - Yahoo
LivaNova PLC Reports Strong Q1 2025 Results - TipRanks
Jefferies lifts Livanova stock price target to $79 from $74 By Investing.com - Investing.com South Africa
LivaNova: Q1 Earnings Snapshot - MySA
LivaNova PLC earnings beat by $0.12, revenue topped estimates - Investing.com Nigeria
LivaNova PLC SEC 10-Q Report - TradingView
Are LivaNova PLC's (NASDAQ:LIVN) Fundamentals Good Enough to Warrant Buying Given The Stock's Recent Weakness? - Yahoo Finance
LivaNova Q1 2025 Earnings Call Transcript - MarketBeat
Will LivaNova's Growth And Innovation Drive Sustained Gains In 2025? - Nasdaq
LivaNova submits nerve stim for sleep apnea to FDA, raises 2025 guidance - MassDevice
LivaNova Q1 Adjusted Earnings, Net Revenue Rise; 2025 Outlook Revised - marketscreener.com
LivaNova PLC Reports Earnings Results for the First Quarter Ended March 31, 2025 - marketscreener.com
LivaNova (LIVN) Q1 Earnings and Revenues Surpass Estimates - Yahoo Finance
LIVN Surpasses Q1 Revenue Expectations with Robust Growth | LIVN Stock News - GuruFocus
LivaNova Reports First-Quarter 2025 Results; Updates 2025 Guidance - BioSpace
LivaNova PLC Q1 2025 Earnings: Revenue Hits $316.9M, Adjusted EPS Soars to $0.88, Both Surpass Estimates - GuruFocus
LIVN Reports Promising 12-Month Results from OSPREY Sleep Apnea Trial | LIVN Stock News - GuruFocus
LivaNova plc (LIVN) Tops Q1 EPS by 12c ; Offers Guidance - StreetInsider
Earnings Flash (LIVN) LIVANOVA PLC Reports Q1 Revenue $316.9M, vs. FactSet Est of $302.4M - marketscreener.com
LivaNova Announces 12-month Data from OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea, Demonstrating Strong Response and Durability of Therapy | LIVN Stock News - GuruFocus
LivaNova Announces 12-Month Data From Osprey Clinical Study For Moderate To Severe Obstructive Sleep Apnea, Demonstrating Strong Response And Durability Of Therapy - marketscreener.com
LivaNova Announces 12-month Data from OSPREY Clinical Study for Moderate to Severe Obstructive Sleep Apnea, Demonstrating Strong Response and Durability of Therapy - Business Wire
Should Weakness in LivaNova PLC's (NASDAQ:LIVN) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials? - simplywall.st
How the (LIVN) price action is used to our Advantage - news.stocktradersdaily.com
Medical Implants Market Projected To Witness Substantial - openPR.com
Is LivaNova PLC (LIVN) the Best Undervalued UK Stock to Buy Right Now? - Insider Monkey
Vagus Nerve Stimulators Market Set to Witness Significant - openPR.com
Mizuho Adjusts Price Target for LivaNova (LIVN) Ahead of Q1 Prev - GuruFocus
What Is LivaNova PLC's (NASDAQ:LIVN) Share Price Doing? - Yahoo Finance
LivaNova PLC (LIVN): Among the Best UK Stocks to Buy According to Billionaires - Insider Monkey
Cardiovascular Devices Market Demand, Growth and Future Scope - openPR.com
Vagus Nerve Stimulators Market Deep Research Report with - openPR.com
With LivaNova PLC (NASDAQ:LIVN) It Looks Like You'll Get What You Pay For - simplywall.st
Aortic Stenosis Market to Witness Massive Growth by 2032 | - openPR.com
10 Best UK Stocks to Buy According to Billionaires - Insider Monkey
LivaNova PLC: Excellent Revenue Earner, Some Short-Term Litigation Concerns (LIVN) - Seeking Alpha
Enovis appoints Damien McDonald as CEO - MedTech Dive
LivaNova stock plunges to 52-week low, touches $36.18 By Investing.com - Investing.com Canada
LivaNova stock plunges to 52-week low, touches $36.18 - Investing.com Australia
Livanova Plc (LIVN) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.11%
0.79%
자본화:
|
볼륨(24시간):